
Milestones Since we began in 2023

SB242 Passed with Overwhelming Support
We successfully passed SB242 with a landslide, establishing the Nevada Psychedelic Medicines Working Group, a pivotal step toward policy reform.

Nevada Psychedelic Medicines Working Group
The Working Group’s final report delivered key recommendations, shaping the future of psychedelic policy in Nevada.
.png)
SJR10 Passed with Strong Bi-Partisan Support
SJR10 urges Congress to reschedule psychedelic medicine, allocate funding for research, and expand access to psychedelic-assisted therapies. With 7 sponsors and 20 cosponsors, it passed strong bipartisan support.
.png)
Introduced AB378 to est. Alternative Therapies Pilot
AB378 would have established an Alternative Therapies Pilot Program for veterans and former first responders. Although the bill did not pass, it garnered strong bipartisan support, with 8 primary sponsors and 16 cosponsors.



Why is the issue of psychedelic drug policy reform critical?
Our state and country are facing a mental health crisis. Current treatments are ineffective and failing, and psychedelic medicines have shown great potential for treating conditions such as anxiety, depression, PTSD, addiction, OCD, eating disorders, and more.






